-
Verteporfin (trade name
Visudyne), a
benzoporphyrin derivative, is a
medication used as a
photosensitizer for
photodynamic therapy to
eliminate the abnormal...
- is
credited for
developing photodynamic therapy (PDT) with
verteporfin (
Visudyne), the
first pharmacologic therapy for
retinal disease. She also co-discovered...
-
macular degeneration Tayyaba Hasan, PhD (Wellman
Center for Photomedicine)
Visudyne Novartis Photodynamic therapy of wet age-related
macular degeneration Tayyaba...
-
introduced generic in 2008 Tyzeca/Sebivo (telbivudine)
Chronic hepatitis B
Visudyne (verteporfin) Age-related
macular degeneration (wet form)
Voltaren (diclofenac)...
-
Photomedicine at
Harvard Medical School. She is one of the
inventors of
Visudyne, a Food and Drug
Administration approved treatment for age-related macular...
- CIBA
Vision (now
Novartis Ophthalmalics)
developed as
Visudyne, a
treatment for AMD.
Visudyne was
approved by the US FDA in 2000 and
throughout the world...
-
Photosensitizers commercially available for
clinical use
include Allumera, Photofrin,
Visudyne, Levulan, Foscan, Metvix, Hexvix,
Cysview and Laserphyrin, with others...
-
accelerating new
treatments and therapies.
Among the system's
recent innovations:
Visudyne for
macular degeneration,
Enbrel for
rheumatoid arthritis,
Eloctate and...
-
vitamin K
supplement and a virostatic, from F. Hoffmann-La
Roche in 2018),
Visudyne (a
photosensitizer used for
photodynamic therapy of the wet form of macular...
-
expert in
porphyrin chemistry and biochemistry. He was the lead
creator of
Visudyne, a
medication used in
conjunction with
laser treatment to
eliminate the...
